By: Chastain Fitzgerald; Originally posted by Population Council
Chastain Fitzgerald is the Chief Program and Development Officer of WomanCare Global
This post is part of a monthly blog series profiling viewpoints from leaders in reproductive health who are members of the Bellagio Group on Long-Acting Reversible Contraception. The Bellagio Group is a coalition of experts that convenes annually to discuss practices for expanding contraceptive choice and accelerating progress toward the Millennium Development Goal of universal access to reproductive health services. This post represents the views of the author and is not a representation of the Population Council or the Bellagio Group. Please direct any questions to the author at firstname.lastname@example.org.
Two weeks ago, I observed a focus group in Lusaka, Zambia, where a moderator from a South African marketing agency spoke with eight young women about their views on contraception. Joined by a local researcher, a program manager, and marketers, I watched the session next door through a live television feed. Our goal was to get a head start on the development of marketing strategies for new contraceptive products—a project funded by USAID. In that small room in the Lusaka office building, we huddled around the television listening to these women’s opinions about different contraceptive options, hoping to understand how they make decisions about which methods to use and how the public health community can better meet their needs. Read more...